Finance

Lists
Why is EPRX down 6.72%?
Dive Deeper
EPRX:TSE
Eupraxia Pharmaceuticals Inc
CA$8.19
-6.72%
(-0.59) 1D
Nov 20, 3:13:31 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for EPRX...
Open
CA$8.62
High
CA$8.81
Low
CA$8.17
Mkt. cap
551.21M
Avg. vol.
95.14K
Volume
32.66K
52-wk high
CA$13.08
52-wk low
CA$7.85
EPS
-CA$1.42
Beta
1.25
Shares outstanding
67.27M
No. of employees
49
Open
CA$8.62
High
CA$8.81
Low
CA$8.17
Mkt. cap
551.21M
Avg. vol.
95.14K
Volume
32.66K
52-wk high
CA$13.08
52-wk low
CA$7.85
EPS
-CA$1.42
Beta
1.25
Shares outstanding
67.27M
No. of employees
49
News stories
From web sources and news partners
About Eupraxia Pharmaceuticals Inc
CEO-
Employees49
Founded2011
HeadquartersVictoria, British Columbia, Canada
SectorHealth Care
IndustryBiotechnology
Last report
Nov 10, 2026
Fiscal period
Q3 2026
-CA$0.33 / -
Revenue / Est. (CAD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.87M
11.17M
12.81M
10.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.30M
4.78M
5.30M
5.34M
Operating expense
16.16M
15.96M
18.10M
16.16M
Total operating expenses
16.16M
15.96M
18.10M
16.16M
Operating income
-16.16M
-15.96M
-18.10M
-16.16M
Other non operating income
-
-
-
-
EBT including unusual items
-16.71M
-12.64M
-14.46M
-15.26M
EBT excluding unusual items
-16.71M
-12.64M
-14.46M
-15.25M
Income tax expense
11.34K
13.90K
30.38K
-7.17K
Effective tax rate
-0.07%
-0.11%
-0.21%
0.05%
Other operating expenses
-
-
-
-
Net income
-16.71M
-12.65M
-14.49M
-15.24M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
666.92K
1.07M
1.39M
1.22M
Interest expense
-
-
-
-
Net interest expenses
666.92K
1.07M
1.39M
1.22M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.11M
-15.90M
-18.02M
-15.90M
Gain or loss from assets sale
1.49K
-
2.70K
1.41K
Upcoming events
AI content may include mistakes. Learn more
Google apps